Researchers at Karolinska Institutet and the University of Gothenburg have identified two types of metabolic-associated fatty liver disease - a...

A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental study, pharmacological...

A study conducted confirmed a suspected connection between poor sleep and metabolic dysfunction-associated steatotic liver disease (MASLD)...

Opioids are often first-line treatments for cancer-related pain, but they can suppress the immune system and reduce the effectiveness of...

AHCC demonstrates potential in preventing liver fibrosis progression by inhibiting HSC activation and regulating key pathways involved in liver...

AHCC demonstrates potential in preventing liver fibrosis progression by inhibiting HSC activation and regulating key pathways involved in liver...

Audience: Gastroenterology, Hepatology, Patient, Health Care Professional, Pharmacy ISSUE: The FDA identified cases of serious liver injury among...

The year 2024 saw interesting developments in the science of cancer treatment, vaccines and genetic discoveries. Two Nobel Prize winners were involved...

Liver disease affects millions of people in the United States, and one of its more serious forms, nonalcoholic fatty liver disease (NAFLD), can have...

December 12, 2024 -- Pilatus Biosciences Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug...